| A Collaboration with Texas Dental Association! |
 |
 |
The School of Dentistry PACE Center is happy to announce its collaboration with the Texas Dental Association to bring six highly-requested continuing dental education courses to you.
In partnership with the TDA, PACE Center will host six CE course offerings of The Opioid Epidemic and Dentists: Scope, Related Issues and Dental Implications of Patients With Substance Use Disorders presented by Dr. Arthur Jeske.
Review details about Dental Concierge and how to register.
Select the text for a guide on how to watch the course.
 |
|
$180 - Dentist | TDA Members $200 - Dentist | Non-TDA Members |
|
A live, interactive webinar presentation. Course fee is due at time of registration. Dental Concierge has a monthly fee of $9.99/month for non-TDA members. A confirmation for registration will not be provided by PACE Center for this course. |
Synopsis
This program is designed to help dentists meet their continuing education requirements for prescribing controlled substances. The course provides an update on the current scope of the opioid epidemic and its impact on pain management in dentistry, and a review of the clinical pharmacologic traits of opioid analgesics and those of non-opioid alternatives for the management of acute dental pain. Additionally, the program will review the dental implications for patients with Substance Use Disorder and strategies to minimize the risk of opioid and controlled substance abuse and diversion. This course satisfies the TSBDE requirement of 4 hours of continuing education on controlled substances every 2 years.
Objectives
Upon completion of the course, the dentist will be able to describe and apply the following during direct patient care:
- Understand the current nature and scope of the opioid epidemic and current issues involving non-opioid controlled substances (e.g., cannabis)
- Select appropriate non-opioid medications for the management of acute dental pain when opioids are contraindicated
- Recognize Substance Use Disorder and apply strategies to prevent diversion and abuse of controlled substances in the dental practice
- Describe strategies for recognizing Substance Use Disorder (SUD) in dental patients and understand the implications of SUD for delivery of dental care to addicted patients
- Understand the role of opioid reversal in the management of opioid overdose reactions and the pharmacologic characteristics of opioid antagonists
Arthur H. Jeske, DMD, PhD, is the Associate Dean for Strategic Planning and Continuing Dental Education and a professor in the Department of General Practice and Dental Public Health at UTHealth Houston School of Dentistry. He earned his PhD in pharmacology and DMD from the Medical College of Georgia. He is a member of the American Dental Association (ADA), Texas Dental Association, and Greater Houston Dental Society and is a fellow of the International College of Dentistry and the American College of Dentistry. Dr. Jeske chaired the ADA's Council on Scientific Affairs in 2004 and has authored numerous articles on the use of drugs in dentistry. He is currently editor-in-chief of Mosby's Dental Drug Reference and an editor of Contemporary Dental Pharmacology.
Date: Friday, September 15, 2023
Time: 11:30 AM CST | webinar link opens
| Presentation: 12:00 PM to 4:00 PM CST |
Live Interactive Webinar Location:
TDA Dental Concierge online platform
340 Prescribing Medication Management (Controlled Substance| Record Keeping) - Lecture: Hours - 2
340 Prescribing Medication Management (Controlled Substance) - Lecture: Hours - 2
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Recognition Program (ADA CERP) through joint efforts between UTHealth Houston School of Dentistry — PACE Center and the Texas Dental Association.
Up to 4 credit hours of continuing dental education may be earned in Prescribing Medication Management | Record Keeping (AGD Code 340).
PACE Center, Continuing Dental Education
Email: PACE@uth.tmc.edu